Julie Allison Weltman

Associate

jweltman@cooley.com

Julie Allison Weltman focuses her practice on the representation of both underwriters and issuers on a variety of capital markets transactions. Julie also regularly counsels publicly traded companies on general corporate matters, including SEC reporting and corporate governance.

Download full bio 

Experience

  • SOPHiA Genetics – $234 Million IPO 

  • VectivBio – $147 Milion IPO 

  • Lumicks Closes $93 Million Series D Financing  

Practices & Industries

Education

  • Harvard Law School
    JD, 2018

  • The University Of Texas at Austin – The Red McCombs School of Business
    BBA, Finance – Corporate Finance and Investment Banking
    2015

  • The University Of Texas at Austin
    BA, Economics and Government
    2015


Admissions & Credentials

New York